Syncona Limited (SYNC.L)
LSE · GBp · Financial Services · Asset Management
£126.80 (+0.48%) as of
Key statistics
- Market cap
- 771.20M
- Forward P/E
- 7.04
- EPS (TTM)
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- 86.80 – 131.80
- Beta
- 0.29
- Revenue (TTM)
- 20.27M
- Profit margin
- -43.43%
- Analyst target
- £202.00
- Volume
- 158.86k
About Syncona Limited
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
- Sector
- Financial Services
- Industry
- Asset Management
- Headquarters
- London, United Kingdom
- Employees
- 1,226
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- PZ CUSSONS PLC ORD 1P (PZC.L)
- AMEDEO AIR FOUR PLUS LIMITED RE (AA4.L)
- ALFA FINANCIAL SOFTWARE HOLDING (ALFA.L)
- SHIELD THERAPEUTICS PLC ORD 1.5 (STX.L)
- BURE EQUITY AB BURE EQUITY ORD (0N7D.IL)
- W.A.G PAYMENT SOLUTIONS PLC ORD (EWG.L)
- REGIONAL REIT LIMITED ORD NPV (RGL.L)
- Fidelity European Trust PLC (FEVL.XC)